Aspen Aerogels Files 8-K on Financials

TL;DR

Aspen Aerogels filed an 8-K on Feb 12, 2025, covering financial results. No major news yet.

AI Summary

On February 12, 2025, Aspen Aerogels, Inc. filed an 8-K report. The filing primarily concerns the company's results of operations and financial condition, along with Regulation FD disclosures and financial statements. No specific financial figures or significant events were detailed in the provided excerpt.

Why It Matters

This filing indicates Aspen Aerogels is providing updates on its financial performance and operational status to the SEC, which is important for investors tracking the company's health.

Risk Assessment

Risk Level: low — The filing is a standard 8-K reporting routine financial information and does not disclose any immediate material risks or significant events.

Key Players & Entities

• Aspen Aerogels, Inc. (company) — Registrant
• February 12, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• Northborough, Massachusetts (location) — Principal Executive Offices
• (508) 691-1111 (phone_number) — Registrant's Telephone Number

FAQ

Filing Documents

• f8k_021225.htm (8-K) — 22KB
• exh_991.htm (EX-99.1) — 126KB
• 0001171843-25-000772.txt ( ) — 334KB
• aspn-20250212_lab.xml (EX-101.LAB) — 33KB
• aspn-20250212_pre.xml (EX-101.PRE) — 22KB
• aspn-20250212.xsd (EX-101.SCH) — 3KB
• f8k_021225_htm.xml (XML) — 4KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On February 12, 2025, Aspen Aerogels, Inc. announced its financial results for the fourth quarter and fiscal year 2024, which ended December 31, 2024, and also discussed business developments. A copy of the press release containing such announcement is attached hereto as Exhibit 99.1. The information set forth in the press release, except for the information set forth under the heading "Q1 2025 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking 8-K.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. The information set forth under the heading "Q1 2025 Financial Outlook" and under the heading "About Aspen Aerogels, Inc.," together with the forward-looking statement disclaimer at the end of the press release, is incorporated by reference into this Item 7.01 of this Current Report on Form 8-K.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Aspen Aerogels, Inc. on February 12, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) The press release may contain hypertext links to information on our website. The information on our website is not incorporated by reference into this Current Report on Form 8-K and does not constitute a part of this Form 8-K. The information contained in this Current Report on Form 8-K and Exhibit 99.1 attached hereto is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Aspen Aerogels, Inc. Date: February 12, 2025 By: /s/ Ricardo C. Rodriguez Name: Ricardo C. Rodriguez Title: Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR